Novartis India Limited (BOM:500672)
India · Delayed Price · Currency is INR 929.80
+9.25 (1.00%)
At close: Mar 5, 2026
Novartis India Market Cap
Novartis India has a market cap or net worth of 22.73 billion as of March 5, 2026. Its market cap has increased by 8.40% in one year.
Market Cap
22.73B
Enterprise Value
16.60B
Revenue
3.48B
Ranking
n/a
PE Ratio
23.38
Stock Price
929.80
Market Cap Chart
Since April 14, 1999, Novartis India's market cap has increased from 12.59B to 22.73B, an increase of 80.60%. That is a compound annual growth rate of 2.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 22.96B | 19.36% |
| Dec 31, 2025 | 19.23B | -15.31% |
| Dec 31, 2024 | 22.71B | 18.95% |
| Dec 29, 2023 | 19.09B | 14.56% |
| Dec 30, 2022 | 16.67B | -12.94% |
| Dec 31, 2021 | 19.14B | 13.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 27.96B |
| Hikal | 23.72B |
| Morepen Laboratories | 22.84B |
| Bliss GVS Pharma | 22.83B |
| Unichem Laboratories | 22.64B |
| Shukra Pharmaceuticals | 17.16B |
| Amrutanjan Health Care | 16.78B |
| Kwality Pharmaceuticals | 15.08B |